Effie W Petersdorf

Summary

Affiliation: The Children's Hospital at Westmead
Country: Australia

Publications

  1. ncbi Busulphan given as four single daily doses of 150 mg/m2 is safe and effective in children of all ages
    P J Shaw
    Department of Oncology, The Children s Hospital at Westmead, NSW, Australia
    Bone Marrow Transplant 34:197-205. 2004
  2. ncbi Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors
    Peter J Shaw
    Children s Hospital at Westmead, Sydney, Australia
    Blood 116:4007-15. 2010

Collaborators

Detail Information

Publications2

  1. ncbi Busulphan given as four single daily doses of 150 mg/m2 is safe and effective in children of all ages
    P J Shaw
    Department of Oncology, The Children s Hospital at Westmead, NSW, Australia
    Bone Marrow Transplant 34:197-205. 2004
    ..Given the reliable pharmacokinetics, low toxicity and high rate of allogeneic engraftment, there is no need for routine pharmacokinetic monitoring or dose modifications. This dosage regimen may be applicable for use with i.v. BU...
  2. ncbi Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors
    Peter J Shaw
    Children s Hospital at Westmead, Sydney, Australia
    Blood 116:4007-15. 2010
    ..Whether allele level typing could identify mmRD recipients with better outcomes will not be known unless centers alter practice and type mmRD at the allele level...